ASCO 2026 marked a clear inflection point in oncology. Brooks Hill Partners breaks down the meeting's defining themes — from pan-KRAS inhibitors unlocking treatment in pancreatic cancer, to bispecific antibodies expanding immunotherapy's reach, and ADCs emerging as a cornerstone of next-generation combination strategies. Underlying it all: a growing imperative to translate scientific breakthroughs into globally equitable access.

Clinical trials, a massive hurdle in the biopharmaceutical world, are often the rate-limiting step in drug development. Not only are clinica

For the past year or so, the US has been grappling with a dire drug shortage crisis. With the number of drugs in short supply reaching a pea

Precision medicine is an emerging field of medicine that aims to tailor disease treatment to people’s genes, environment, and lifestyle.

Given this rising interest in integrative medicine, some biopharma companies are bringing the patient's perspective into their R&D process.